pharma
publication date
Revenue Cycle
Infographic: Are Drug Companies or Hospitals More Likely to Violate 340B Rules?
In a recent analysis of HRSA data, the American Hospital Association has turned the tables on drug companies and accused...
CEO
Walgreens Falls into the Red in Q3 With Sycamore Acquisition Looming
The company reported a quarterly loss as it prepares to be acquired and transformed by the private equity firm.
CFO
Infographic:The CFO Regulatory Guide: 3 Tips for Navigating the Chaos
From tariffs, to Medicaid, to PBMs, here?s what to know.
CFO
Hospitals Get $700M From Drugmakers in Opioid Class-Action Lawsuit
The opioid epidemic has affected hospitals, both clinically and financially, for almost 30 years.
Payer
Contributed Content: 2 Alternatives to Ineffective Prescription Drug Rebates
Prescription drug rebates were once a good idea. Not any more.
Pharma
Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma's Weight Loss Drugs
Large compounding pharmacies are provisioning up to 2 million American patients with semaglutide.
CFO
Infographic: 5 Must-Know Tips for CFO Success
Top finance executives share their tips on how to succeed in today's volatile healthcare economy.
CFO
3 Areas Where CFOs Are Laser Focused
"We are not going to leave dollars on the table," CFOs say.
Pharma
Beacon Therapeutics CEO Puts Patients First in Mission to Prevent Blindness
David Fellows is guided by listening to patients and their families as they prepare for one of life?s worst moments--a...
Pharma
Indiana AG Sues Drugmakers, PBMs Over High Insulin Prices
The suit says diabetes care costs the Hoosier State $5 billion annually.
Pharma
Astellas' Chief Strategy Officer Meets Challenges of New Role, And New Diagnosis
Adam Pearson?s life experiences and a recent diagnosis of a rare disease give him a unique perspective to guide the...
Pharma
Roche's Digital Health Chief Puts Teamwork Over Technology
Stephen Ranjan believes teamwork is just as crucial as technology in building successful digital healthcare solutions in the pharma space